Biotechnology
TLX
9.74
price up icon0.83%   0.08
pre-market  Vorhandelsmarkt:  9.78   0.04   +0.41%

Telix Pharmaceuticals Ltd Adr (TLX)
full-star
loading
Überblick Nachrichten Preisverlauf Forum Prognose
Schlusskurs vom Vortag:
$9.66
Offen:
$9.66
24-Stunden-Volumen:
123.22K
Relative Volume:
0.90
Marktkapitalisierung:
$3.26B
Einnahmen:
$417.75M
Nettoeinkommen (Verlust:
$32.27M
KGV:
99.90
EPS:
0.0975
Netto-Cashflow:
-
1W Leistung:
-0.10%
1M Leistung:
-5.25%
6M Leistung:
-44.28%
1J Leistung:
-40.43%
1-Tages-Spanne:
Value
$9.57
$9.80
1-Wochen-Bereich:
Value
$9.3701
$9.975
52-Wochen-Spanne:
Value
$8.76
$30.36

Telix Pharmaceuticals Ltd Adr Stock (TLX) Company Profile

Name
Firmenname
Telix Pharmaceuticals Ltd Adr
Name
Sektor
Healthcare (1131)
Name
Branche
Biotechnology (632)
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
554
Name
Twitter
Name
Nächster Verdiensttermin
2025-10-14
Name
Neueste SEC-Einreichungen
Name
TLX's Discussions on Twitter

Vergleichen Sie TLX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TLX
Telix Pharmaceuticals Ltd Adr
 9.74 3.23B 417.75M 32.27M 0 0.0975
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 457.26 117.50B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 722.83 76.06B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 464.56 62.53B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
 916.31 56.75B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
 205.04 44.10B 447.02M -1.18B -906.14M -6.1812

Telix Pharmaceuticals Ltd Adr Stock (TLX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-18 Eingeleitet Citigroup Buy
2025-08-28 Herabstufung JP Morgan Overweight → Neutral
2025-07-03 Eingeleitet H.C. Wainwright Buy
2025-06-05 Eingeleitet Wedbush Outperform
2024-11-15 Eingeleitet UBS Buy

Telix Pharmaceuticals Ltd Adr Aktie (TLX) Neueste Nachrichten

pulisher
Dec 04, 2025

TLX Class Action Reminder: Telix Pharmaceuticals Ltd. Stockholders Should Contact Robbins LLP for Information About Leading the Class Action Against TLX - GlobeNewswire Inc.

Dec 04, 2025
pulisher
Dec 02, 2025

ATTENTION NASDAQ: TLX INVESTORS: Contact Berger Montague About a Telix Pharmaceuticals Ltd. Class Action Lawsuit - Stock Titan

Dec 02, 2025
pulisher
Dec 01, 2025

Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately - Finviz

Dec 01, 2025
pulisher
Nov 28, 2025

Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman - Finviz

Nov 28, 2025
pulisher
Nov 26, 2025

Telix Pharmaceuticals (TLX) Hit with Investor Lawsuit Alleging Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman - Finviz

Nov 26, 2025
pulisher
Nov 25, 2025

Investors in Telix Pharmaceuticals Ltd. Should Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your RightsTLX - Finviz

Nov 25, 2025
pulisher
Nov 25, 2025

Berger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors After Class Action Filing - Stock Titan

Nov 25, 2025
pulisher
Nov 24, 2025

TLXTelix Pharmaceuticals Ltd ADR Latest Stock News & Market Updates - Stock Titan

Nov 24, 2025
pulisher
Nov 19, 2025

Berger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) After Class Action Filing - Stock Titan

Nov 19, 2025
pulisher
Nov 18, 2025

Telix Pharmaceuticals Limited Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsTLX - Stock Titan

Nov 18, 2025
pulisher
Oct 20, 2025

Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action InvestigationTLX - cnhinews.com

Oct 20, 2025
pulisher
Oct 16, 2025

ContactThe Lethbridge HeraldNews and Sports from around Lethbridge - FinancialContent

Oct 16, 2025
pulisher
Oct 12, 2025

TLX Investor News: If You Have Suffered Losses in Telix - GlobeNewswire

Oct 12, 2025
pulisher
Sep 11, 2025

TELIX ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Sep 11, 2025
pulisher
Sep 11, 2025

About Us - FinancialContent

Sep 11, 2025
pulisher
Sep 03, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals LimitedTLX - cnhinews.com

Sep 03, 2025
pulisher
Aug 29, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX - Morningstar

Aug 29, 2025
pulisher
Aug 29, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX | Salt Lake City News, Weather, Sports, Breaking News | KUTV - FinancialContent

Aug 29, 2025
pulisher
Aug 28, 2025

Telix stock plunges after FDA issues Complete Response Letter - Investing.com

Aug 28, 2025
pulisher
Aug 28, 2025

Telix stock plunges after FDA issues Complete Response Letter By Investing.com - Investing.com Nigeria

Aug 28, 2025
pulisher
Aug 28, 2025

Telix Shares Drop After FDA Issues Complete Response Letter - MSN

Aug 28, 2025

Finanzdaten der Telix Pharmaceuticals Ltd Adr-Aktie (TLX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie TLX

biotechnology RPRX
$39.16
price down icon 1.10%
biotechnology INCY
$100.48
price down icon 1.00%
biotechnology GMAB
$32.03
price up icon 1.10%
biotechnology BNTX
$95.99
price down icon 0.77%
biotechnology ONC
$331.27
price down icon 1.95%
biotechnology INSM
$205.04
price down icon 0.84%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):